2-Bromo-4-(trifluoromethyl)oxazole - CAS 1060816-14-9
Catalog: |
BB001806 |
Product Name: |
2-Bromo-4-(trifluoromethyl)oxazole |
CAS: |
1060816-14-9 |
Synonyms: |
2-bromo-4-(trifluoromethyl)oxazole; 2-bromo-4-(trifluoromethyl)-1,3-oxazole |
IUPAC Name: | 2-bromo-4-(trifluoromethyl)-1,3-oxazole |
Description: | 2-Bromo-4-(trifluoromethyl)oxazole (CAS# 1060816-14-9 ) is a useful research chemical. |
Molecular Weight: | 215.96 |
Molecular Formula: | C4HBrF3NO |
Canonical SMILES: | C1=C(N=C(O1)Br)C(F)(F)F |
InChI: | InChI=1S/C4HBrF3NO/c5-3-9-2(1-10-3)4(6,7)8/h1H |
InChI Key: | GOJLDYZMFAQWAN-UHFFFAOYSA-N |
LogP: | 2.45590 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
EP-3825303-A1 | T-type calcium channel blocker | 20180717 |
CN-110022875-A | Therapeutic inhibiting compound | 20160711 |
AU-2014336258-A1 | Piperazine derivatives and the use thereof as medicament | 20131016 |
AU-2014336258-B2 | Piperazine derivatives and the use thereof as medicament | 20131016 |
CA-2926754-A1 | Piperazine derivatives and the use thereof as medicament | 20131016 |
Complexity: | 128 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 214.91936 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 5 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 214.91936 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 26 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Oxazole/Thiazole
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS